Jazz Pharmaceuticals plc (JAZZ) › RevenueJazz Pharmaceuticals plc (JAZZ) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $1.49B2017: $1.62B2018: $1.89B2019: $2.16B2020: $2.36B2021: $3.09B2022: $3.66B2023: $3.83B2024: $4.07B2025: $4.27B$4.27B2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$4.27B+4.9%2024$4.07B+6.1%2023$3.83B+4.8%2022$3.66B+18.3%2021$3.09B+30.9%2020$2.36B+9.3%2019$2.16B+14.3%2018$1.89B+16.8%2017$1.62B+8.8%2016$1.49B—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share